One of the proposed methods of detection is an antibody assay utilizing fluorescently labelled antibodies.
Rapid release of soluble form of the molecules could serve to neutralize deleterious antibodies.
A decline in the advantage of carbohydrates can be expected, if a virus variant has adapted to affect young people whose antibody status is poor.
Also, a decrease in the antibody level after treatment in connection with the presence of risk factors was estimated.
If the participation of the former type of antibody were predominant or exclusive, sera would show similar reactivities against all antigens.
Conversely, antibody production is controlled by the probability of antibodies (or antibody-producing cells) encountering bacteria (or being presented with antigens derived from these pathogens).
Treatment just before the antibodies are triggered results in a very high probability of selecting a drug-resistant population.
We have also reviewed studies involving animal models, the analysis of human antibody sequences and studies of, and using, computer modelling and crystal structure.
